Pulmonary Pharmacology & Therapeutics

杂志介绍

Pulmonary Pharmacology & Therapeutics杂志介绍

《Pulmonary Pharmacology & Therapeutics》是一本以English为主的未开放获取国际优秀期刊，中文名称肺药理学与治疗学，本刊主要出版、报道医学-PHARMACOLOGY & PHARMACY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为3.3，最新CiteScore 指数为6.2。

本刊近期中国学者发表的论文主要有：

• Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway

  Author: Guangxia Yang, Lei Lyu, Xinhua Wang, Liang Bao, Beili Lyu, Zikai Lin

• GYY4137 attenuates LPS-induced acute lung injury via heme oxygenase-1 modulation

  Author: Lei Jiang, Qing Jiang, Songlin Yang, Shicong Huang, Xiaoli Han, Jun Duan, Shangha Pan, Mingyan Zhao, Shuliang Guo

• Arbutin attenuates LPS-induced lung injury via Sirt1/ Nrf2/ NF-κBp65 pathway

  Author: Jinyan Ye, Minqiang Guan, Yao Lu, Dan Zhang, Chengye Li, Caicun Zhou

• Effect of mesenchymal stromal (stem) cell (MSC) transplantation in asthmatic animal models: A systematic review and meta-analysis

  Author: Li-Bo Zhang, Min He

英文介绍

Pulmonary Pharmacology & Therapeutics杂志英文介绍

Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.

Research Areas Include:

• All major diseases of the lung

• Physiology

• Pathology

• Drug delivery

• Metabolism

• Pulmonary Toxicology.